Allpharma Care Private Limited logo

Allpharma Care Private Limited

Pharmaceutical company manufacturing a wide range of products including acebrophylline, amitriptyline, and aspirin.
2016 | Mumbai, Maharashtra (India) | Active

Last Updated:

January 07, 2025
HomeCompanyAllpharma Care Private Limited

Who are the key members and board of directors at Allpharma Care?

Board Members(2)

NameDesignationAppointment DateStatus
Amit Agarwal In Director 16-May-2016Current
Amish Shah In Director 16-May-2016Current

Financial Performance of Allpharma Care.

Allpharma Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.67% increase. The company also saw a substantial improvement in profitability, with a 10.12% increase in profit. The company's net worth Soared by an impressive increase of 31.83%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
39.67%
Revenue from Operations
39.85%
Total Assets
27.82%
Profit or Loss
10.12%
Net Worth
31.83%
EBITDA
22.36%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹3.00 M

LenderAmountStatus

Others

Creation Date: 03 Aug 2018
₹3.00 MOpen

How Many Employees Work at Allpharma Care?

Unlock and access historical data on people associated with Allpharma Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Allpharma Care

Recent activity within the organization

  • Annual General Meeting

    Allpharma Care Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Allpharma Care Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Charges

    A charge with Others amounted to Rs. 3.00 M with Charge ID 100195302 was registered on 03 Aug 2018.

    03 Aug 2018

  • Director Appointment

    Amit Radheyshyam Agarwal was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 8 years 7 months .

    16 May 2016

  • Director Appointment

    Amish Ramesh Shah was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 8 years 7 months .

    16 May 2016

  • Company Incorporation

    Allpharma Care Private Limited was registered on 16 May 2016 with Roc Mumbai & aged 8 years 7 months as per MCA records.

    16 May 2016

Frequently asked questions

  • Allpharma Care Private Limited was incorporated on 16 May 2016.

  • The authorized share capital of Allpharma Care Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Allpharma Care Private Limited.

    • Amit Radheyshyam Agarwal
    • Amish Ramesh Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Allpharma Care Private Limited is 207 Floor-2 Plot-49 Vyapar Bhavan P D Mello Road, Carnac Bunder Chinchbunder India, Mumbai, Maharashtra, 400009.

  • The corporate identification number (CIN) of Allpharma Care Private Limited is U74999MH2016PTC281202 and the company number is 281202 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Allpharma Care Private Limited is https://www.allpharmacare.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Allpharma Care Private Limited has risen by 39.67%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Allpharma Care Private Limited has experienced an upsurge of 31.83%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Allpharma Care Private Limited amount to ₹ 3.00 M.

  • The most recent Balance Sheet for Allpharma Care Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development